Syneos Health Executive and Leadership Team

Costa Panagos, the Chief Executive Officer at Syneos Health, directs the overarching corporate strategy and global vision for the biopharmaceutical research organization. Overseeing operations across more than 110 countries, the Chief Executive Officer ensures alignment between clinical trial execution and commercialization goals. This leadership role involves driving innovation in drug development to accelerate therapy delivery for pharmaceutical and biotechnology clients. By fostering a culture of operational excellence, Costa Panagos maintains the company's competitive edge in the life sciences sector. The Chief Executive Officer collaborates with the Board to optimize resource allocation and expand market reach throughout the Americas, Europe, and Asia Pacific. Through rigorous oversight of integrated service delivery, Panagos secures long-term growth and enhances the firm's reputation as a premier partner for complex healthcare organizations seeking to navigate modern regulatory and market landscapes.

Phil Deschamps, the President and Chief Executive Officer, GSW Worldwide at Syneos Health, leads the specialized advertising and communications division focused on healthcare branding. Directing creative strategy and market positioning, the President and Chief Executive Officer, GSW Worldwide ensures that therapeutic messaging resonates with both medical professionals and patient populations. This role involves managing high-impact campaigns that support the commercial success of new medical products. By integrating deep scientific knowledge with consumer insights, Phil Deschamps drives the development of effective marketing solutions that differentiate client brands in crowded global markets. The President and Chief Executive Officer, GSW Worldwide coordinates with clinical teams to ensure that promotional activities remain compliant and scientifically accurate. Deschamps fosters innovation within the agency, pushing boundaries in digital engagement and patient-centric communication to maximize the market impact of life-saving therapies.

Michael Bonello, the Chief Financial Officer at Syneos Health, manages the financial health and fiscal strategy of the global biopharmaceutical services provider. Overseeing capital allocation, financial reporting, and investor relations, the Chief Financial Officer ensures the company maintains a robust balance sheet to support ongoing research and development initiatives. This leadership role involves analyzing market trends to guide investment in advanced technologies and data-driven platforms. By directing financial planning and analysis, Michael Bonello supports the organization's expansion across diverse international regions. The Chief Financial Officer collaborates with executive leadership to assess the profitability of clinical and commercial service lines, ensuring sustainable growth. Bonello drives fiscal discipline across all departments, providing the necessary resources to meet client demands while delivering value to stakeholders. Through strategic financial oversight, the Chief Financial Officer strengthens the firm's position within the competitive life sciences industry.

Alan Birtchet, the Chief Operating Officer, Selling Solutions at Syneos Health, architects the operational framework for the company's commercial deployment services. Overseeing the execution of field-based sales teams and medical representative programs, the Chief Operating Officer, Selling Solutions ensures that pharmaceutical clients achieve optimal market penetration. This role involves streamlining internal processes to enhance the efficiency of commercial strategy implementation across North America and international markets. By leveraging data-driven insights, Alan Birtchet optimizes the deployment of resources to meet specific therapeutic launch requirements. The Chief Operating Officer, Selling Solutions coordinates with cross-functional teams to align sales force activities with broader clinical milestones. Birtchet drives performance improvements in commercial operations, ensuring that the organization delivers consistent, high-quality results for biotechnology partners. Through meticulous operational management, the Chief Operating Officer, Selling Solutions supports the rapid scaling of commercial initiatives in the global healthcare sector.

Jd Cassidy, the President, Syneos Health Advertising (North America) at Syneos Health, leads the regional advertising and marketing operations focused on the North American life sciences market. Directing creative strategy and client engagement, the President, Syneos Health Advertising (North America) ensures that promotional efforts effectively communicate the value of new therapies to healthcare providers and patients. This role involves managing large-scale campaigns that support the commercial launch of medical products. By leveraging regional market insights, Jd Cassidy drives the development of innovative advertising solutions that meet the specific needs of the North American healthcare landscape. The President, Syneos Health Advertising (North America) coordinates with clinical and commercial teams to ensure that all marketing activities are aligned with broader corporate objectives. Cassidy fosters a culture of creativity and excellence, ensuring that the agency delivers impactful results that drive market adoption for client therapies.

Paul Mignon, the President and Global Head Selling Solutions at Syneos Health, directs the international strategy for commercial deployment and sales force effectiveness. Overseeing global operations for selling solutions, the President and Global Head Selling Solutions ensures that pharmaceutical clients receive tailored support to maximize product reach. This role involves managing complex commercial partnerships across diverse geographic regions, including Asia Pacific, Africa, and the Americas. By implementing advanced sales analytics and training, Paul Mignon drives performance improvements in commercial teams worldwide. The President and Global Head Selling Solutions collaborates with clinical leadership to ensure a seamless transition from trial to market. Mignon leads the expansion of commercial services, identifying new opportunities to support biotechnology organizations in their growth efforts. Through strategic global oversight, the President and Global Head Selling Solutions enhances the company's ability to deliver integrated commercial solutions that improve patient access to essential therapies.

Mark Jazvac, the President, Canada at Syneos Health, leads the company's operations and strategic growth within the Canadian market. Overseeing the delivery of clinical and commercial services, the President, Canada ensures that local pharmaceutical and biotechnology clients receive high-quality support tailored to the regional healthcare environment. This role involves managing cross-functional teams to execute clinical trials and commercial strategies effectively. By fostering relationships with local healthcare organizations, Mark Jazvac drives the adoption of the company's integrated solutions. The President, Canada coordinates with global leadership to align regional activities with the firm's overarching mission. Jazvac manages the operational scale of the Canadian business, ensuring that resources are optimized to meet the unique regulatory and market demands of the region. Through dedicated leadership, the President, Canada supports the organization's goal of accelerating therapy development and improving patient outcomes within the Canadian life sciences sector.

Simon Bartle, the Chief Human Resources Officer at Syneos Health, directs the global talent strategy and organizational development for the biopharmaceutical services firm. Overseeing recruitment, employee engagement, and leadership development, the Chief Human Resources Officer ensures the company attracts and retains top-tier scientific and commercial talent. This role involves building a high-performance culture that supports the delivery of complex clinical and consulting services. By implementing comprehensive training programs, Simon Bartle aligns the workforce with the evolving needs of the life sciences industry. The Chief Human Resources Officer collaborates with executive leadership to foster diversity and inclusion across international operations. Bartle drives initiatives that enhance employee productivity and well-being, ensuring the organization remains agile in a competitive global market. Through strategic human capital management, the Chief Human Resources Officer supports the company's mission to bring therapies to market faster by empowering the people behind the research.

Kevin Funkhouser, the Syneos Operations Chief of Staff at Syneos Health, coordinates strategic initiatives and operational workflows across the organization's diverse service divisions. Overseeing the integration of clinical and commercial project management, the Syneos Operations Chief of Staff ensures that executive priorities translate into actionable results. This role involves facilitating communication between the C-suite and operational teams to maintain alignment on corporate goals. By streamlining internal processes, Kevin Funkhouser enhances the efficiency of service delivery for pharmaceutical and biotechnology clients. The Syneos Operations Chief of Staff manages complex cross-functional projects that span global regions, ensuring that resources are utilized effectively to meet project timelines. Funkhouser drives organizational agility by identifying bottlenecks and implementing solutions that improve overall performance. Through dedicated operational oversight, the Syneos Operations Chief of Staff supports the company's commitment to providing integrated solutions that address modern healthcare challenges.

Gregory Licholai, the Chief Medical Officer at Syneos Health, provides clinical leadership and scientific expertise to guide the company's research and development services. Overseeing medical affairs and clinical trial integrity, the Chief Medical Officer ensures that all projects adhere to the highest standards of safety and efficacy. This role involves advising pharmaceutical and biotechnology clients on complex medical strategies to accelerate the path from discovery to market. By integrating clinical insights into commercial planning, Gregory Licholai drives the development of therapies that address significant unmet patient needs. The Chief Medical Officer collaborates with regulatory teams to navigate the complexities of global health authorities. Licholai leads the scientific vision of the organization, ensuring that data-driven approaches remain at the core of all clinical operations. Through expert medical guidance, the Chief Medical Officer supports the firm's mission to improve patient outcomes worldwide.